Division of Medical Imaging Products (DMIP)
Director: Rafel "Dwaine" Rieves, M.D.
Deputy Director: Louis Marzella, M.D., Ph.D.
Deputy Director of Safety: Ira Krefting, M.D.
Chief, Project Management Staff: Kyong "Kaye" Kang, Pharm.D.
The Division of Medical Imaging Products (DMIP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for small molecule agents and biologics used in medical imaging.
- The medical imaging products include contrast agents and radiolabeled pharmaceuticals used for diagnostic purposes. The imaging products also include decorporation agents used to treat individuals exposed to particulate radioactive materials.
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Medical Imaging Products
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2050
Fax: (301) 796-9848